Fundraising Fox

Precision IBD

Encinitas, US · Founded 2016 · Delaware corporation

Biotech

Founders & leadership

RJ
ROLF J. BENIRSCHKENamed on SEC filing
WS
WILLIAM SANDBORN, M.D.Named on SEC filing
DF
DOUGLAS F. WALLNamed on SEC filing
SL
SCOTT L. GLENNNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$111.8M disclosed across 4 rounds · 2017–2020

▶$50MraisedNov 2020 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joy Ghosh, Ph.D.Director
  • Martin Hendrix, Ph.D.Director
  • James D. LaurDirector
  • Joseph C. PapaDirector
  • William Sandborn, M.D.Director
  • Adam StoneDirector
  • Shierley WidjajaDirector
  • Tadataka Tachi Yamada, M.D.Director
  • Mark McKennaExecutive Officer, Director
  • Keith W. Marshall, Ph.D.Executive Officer
  • Laurens Kruidenier, Ph.D.Executive Officer
  • Allison Luo, M.D.Executive Officer
  • Lauren G. OtsukiExecutive Officer
Offering amount
$130M
Amount sold
$50M
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48.1MraisedApr 2020 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • SHLOMO MELMEDDirector
  • GREGORY BEHARDirector
  • LAUREN OTSUKIExecutive Officer
  • MARK MCKENNAExecutive Officer, Director
  • DOUGLAS WALLDirector
  • CHRIS SLAVINSKYExecutive Officer
  • LAURENS KRUIDENIER, PH.D.Executive Officer
  • SHIERLEY WIDJAJADirector
  • ALLISON LUO, M.D.Executive Officer
  • MARK STENHOUSEDirector
  • WILLIAM SANDBORN, M.D.Director
  • JAMES LAURDirector
  • TADATAKA YAMADA, M.D.Director
  • MIKE WALTHERExecutive Officer
  • THIERRY DERVIEUX, PHARM D., PH.D.Executive Officer
Offering amount
$60M
Amount sold
$48.1M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.1MraisedNov 2018 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • WILLIAM SANDBORN, M.D.Director
  • TADATAKA YAMADADirector
  • DOUGLAS F. WALLDirector
  • MARK STENHOUSEDirector
  • STEPHAN TARGANDirector
  • SCOTT L. GLENNExecutive Officer, Director
  • GERALD T. PROEHLDirector
  • ROLF J. BENIRSCHKEDirector
  • SHLOMO MELMEDDirector
Offering amount
$20M
Amount sold
$10.1M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.7MraisedOct 2017 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROLF J. BENIRSCHKEDirector
  • WILLIAM SANDBORN, M.D.Director
  • DOUGLAS F. WALLDirector
  • SCOTT L. GLENNExecutive Officer, Director
Offering amount
$10M
Amount sold
$3.7M
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Precision IBD raised?
Precision IBD has disclosed $111.8M raised across 4 rounds.
Where is Precision IBD headquartered?
Precision IBD is headquartered in Encinitas, US.